Neogen Return on Investment 2012-2025 | NEOG
Current and historical return on investment (ROI) values for Neogen (NEOG) over the last 10 years.
| Neogen ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2025-11-30 | $-0.63B | $2.90B | -20.38% |
| 2025-08-31 | $-1.08B | $2.91B | -33.28% |
| 2025-05-31 | $-1.06B | $2.95B | -30.14% |
| 2025-02-28 | $-0.44B | $3.55B | -11.53% |
| 2024-11-30 | $-0.43B | $3.56B | -10.99% |
| 2024-08-31 | $0.04B | $4.02B | 1.02% |
| 2024-05-31 | $0.06B | $4.03B | 1.44% |
| 2024-02-29 | $0.07B | $4.03B | 1.69% |
| 2023-11-30 | $0.07B | $4.03B | 1.79% |
| 2023-08-31 | $0.05B | $4.03B | 1.24% |
| 2023-05-31 | $0.04B | $4.02B | 1.23% |
| 2023-02-28 | $0.03B | $4.01B | 1.59% |
| 2022-11-30 | $0.02B | $4.03B | 2.18% |
| 2022-08-31 | $0.04B | 0.00% | |
| 2022-05-31 | $0.06B | 0.00% | |
| 2022-02-28 | $0.06B | 0.00% | |
| 2021-11-30 | $0.07B | 0.00% | |
| 2021-08-31 | $0.08B | 0.00% | |
| 2021-05-31 | $0.07B | 0.00% | |
| 2021-02-28 | $0.07B | 0.00% | |
| 2020-11-30 | $0.07B | 0.00% | |
| 2020-08-31 | $0.07B | 0.00% | |
| 2020-05-31 | $0.07B | 0.00% | |
| 2020-02-29 | $0.07B | 0.00% | |
| 2019-11-30 | $0.07B | 0.00% | |
| 2019-08-31 | $0.07B | 0.00% | |
| 2019-05-31 | $0.07B | 0.00% | |
| 2019-02-28 | $0.07B | 0.00% | |
| 2018-11-30 | $0.07B | 0.00% | |
| 2018-08-31 | $0.07B | 0.00% | |
| 2018-05-31 | $0.07B | 0.00% | |
| 2018-02-28 | $0.07B | 0.00% | |
| 2017-11-30 | $0.07B | 0.00% | |
| 2017-08-31 | $0.07B | 0.00% | |
| 2017-05-31 | $0.07B | 0.00% | |
| 2017-02-28 | $0.06B | 0.00% | |
| 2016-11-30 | $0.06B | 0.00% | |
| 2016-08-31 | $0.06B | 0.00% | |
| 2016-05-31 | $0.06B | 0.00% | |
| 2016-02-29 | $0.06B | 0.00% | |
| 2015-11-30 | $0.06B | 0.00% | |
| 2015-08-31 | $0.06B | 0.00% | |
| 2015-05-31 | $0.05B | 0.00% | |
| 2015-02-28 | $0.05B | 0.00% | |
| 2014-11-30 | $0.05B | 0.00% | |
| 2014-08-31 | $0.04B | 0.00% | |
| 2014-05-31 | $0.04B | 0.00% | |
| 2014-02-28 | $0.04B | 0.00% | |
| 2013-11-30 | $0.04B | 0.00% | |
| 2013-08-31 | $0.04B | 0.00% | |
| 2013-05-31 | $0.04B | 0.00% | |
| 2013-02-28 | $0.04B | 0.00% | |
| 2012-11-30 | $0.04B | 0.00% | |
| 2012-08-31 | $0.04B | 0.00% | |
| 2012-05-31 | $0.03B | 0.00% | |
| 2012-02-29 | $0.03B | 0.00% | |
| 2011-11-30 | $0.03B | 0.00% | |
| 2011-08-31 | $0.04B | 0.00% | |
| 2011-05-31 | $0.04B | 0.00% | |
| 2011-02-28 | $0.04B | 0.00% | |
| 2010-11-30 | $0.03B | 0.00% | |
| 2010-08-31 | $0.03B | 0.00% | |
| 2010-05-31 | $0.03B | 0.00% | |
| 2010-02-28 | $0.03B | 0.00% | |
| 2009-11-30 | $0.02B | 0.00% | |
| 2009-08-31 | $0.02B | 0.00% | |
| 2009-05-31 | $0.02B | 0.00% | |
| 2009-02-28 | $0.02B | 0.00% | |
| 2008-11-30 | $0.02B | 0.00% | |
| 2008-08-31 | $0.02B | 0.00% | |
| 2008-05-31 | $0.02B | 0.00% | |
| 2008-02-29 | $0.02B | 0.00% | |
| 2007-11-30 | $0.02B | 0.00% | |
| 2007-08-31 | $0.02B | 0.00% | |
| 2007-05-31 | $0.01B | 0.00% | |
| 2007-02-28 | $0.01B | 74.67% | |
| 2006-11-30 | $0.01B | 34.90% | |
| 2006-08-31 | $0.01B | 32.21% | |
| 2006-05-31 | $0.01B | $0.08B | 29.53% |
| 2006-02-28 | $0.01B | $0.07B | 48.65% |
| 2005-11-30 | $0.01B | 64.29% | |
| 2005-08-31 | $0.01B | 29.09% | |
| 2005-05-31 | $0.01B | 17.28% | |
| 2005-02-28 | $0.01B | $0.06B | 14.95% |
| 2004-11-30 | $0.01B | $0.05B | 15.31% |
| 2004-08-31 | $0.01B | $0.05B | 15.76% |
| 2004-05-31 | $0.01B | $0.05B | 21.19% |
| 2004-02-29 | $0.01B | $0.05B | 32.32% |
| 2003-11-30 | $0.01B | $0.05B | 58.33% |
| 2003-08-31 | $0.01B | 0.00% | |
| 2003-05-31 | $0.01B | 0.00% | |
| 2003-02-28 | $0.01B | 0.00% | |
| 2002-11-30 | $0.01B | 0.00% | |
| 2002-08-31 | $0.01B | 72.73% | |
| 2002-05-31 | $0.01B | 31.25% | |
| 2002-02-28 | $0.01B | 21.51% | |
| 2001-11-30 | $0.01B | $0.03B | 16.53% |
| 2001-08-31 | $0.00B | $0.03B | 13.91% |
| 2001-05-31 | $0.00B | $0.03B | 14.55% |
| 2001-02-28 | $0.00B | $0.03B | 14.95% |
| 2000-11-30 | $0.00B | $0.03B | 15.38% |
| 2000-08-31 | $0.00B | $0.03B | 11.76% |
| 2000-05-31 | $0.00B | $0.03B | 11.88% |
| 2000-02-29 | $0.00B | $0.03B | 8.08% |
| 1999-11-30 | $0.00B | $0.03B | 8.16% |
| 1999-08-31 | $0.00B | $0.03B | 12.24% |
| 1999-05-31 | $0.00B | $0.02B | 12.37% |
| 1999-02-28 | $0.01B | $0.02B | 32.99% |
| 1998-11-30 | $0.01B | $0.03B | 28.87% |
| 1998-08-31 | $0.01B | $0.02B | 50.00% |
| 1998-05-31 | $0.01B | $0.02B | 83.33% |
| 1998-02-28 | $0.01B | $0.02B | 116.67% |
| 1997-11-30 | $0.01B | 0.00% | |
| 1997-08-31 | $0.01B | 140.00% | |
| 1997-05-31 | $0.01B | 140.00% | |
| 1997-02-28 | $0.01B | 140.00% | |
| 1996-11-30 | $0.00B | $0.02B | 53.33% |
| 1996-08-31 | $0.00B | 84.21% | |
| 1996-05-31 | $0.00B | 28.57% | |
| 1996-02-29 | $0.00B | $0.01B | 0.00% |
| 1995-11-30 | $0.00B | $0.01B | 0.00% |
| 1995-08-31 | $0.00B | $0.01B | 0.00% |
| 1995-05-31 | $0.00B | $0.01B | 0.00% |
| 1995-02-28 | $0.00B | $0.01B | 0.00% |
| 1994-11-30 | $0.00B | $0.01B | 0.00% |
| 1994-08-31 | $0.00B | $0.01B | 0.00% |
| 1994-05-31 | $0.00B | $0.01B | 0.00% |
| 1994-02-28 | $0.00B | $0.01B | 0.00% |
| 1993-11-30 | $0.00B | $0.01B | 0.00% |
| 1993-08-31 | $0.00B | $0.01B | 0.00% |
| 1993-05-31 | $0.00B | $0.01B | 0.00% |
| 1993-02-28 | $0.00B | $0.01B | 0.00% |
| 1992-11-30 | $0.00B | $0.01B | 0.00% |
| 1992-08-31 | $0.00B | $0.01B | 0.00% |
| 1992-05-31 | $0.00B | $0.01B | 0.00% |
| 1992-02-29 | $0.00B | $0.01B | 0.00% |
| 1991-11-30 | $0.00B | $0.01B | 0.00% |
| 1991-08-31 | $0.00B | $0.01B | 0.00% |
| 1991-05-31 | $0.00B | $0.01B | -12.90% |
| 1991-02-28 | $0.00B | $0.01B | -12.50% |
| 1990-11-30 | $0.00B | $0.01B | -11.76% |
| 1990-08-31 | $0.00B | $0.01B | -11.43% |
| 1990-05-31 | $0.00B | $0.01B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.349B | $0.895B |
| Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $192.719B | 21.52 |
| EssilorLuxottica (ESLOY) | France | $140.970B | 0.00 |
| Stryker (SYK) | United States | $137.019B | 26.29 |
| Medtronic (MDT) | Ireland | $131.919B | 18.28 |
| Boston Scientific (BSX) | United States | $113.066B | 25.01 |
| Medline (MDLN) | United States | $62.139B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.969B | 0.00 |
| ResMed (RMD) | United States | $39.571B | 26.42 |
| GE HealthCare Technologies (GEHC) | United States | $36.756B | 17.61 |
| Agilent Technologies (A) | United States | $36.736B | 23.22 |
| Koninklijke Philips (PHG) | Netherlands | $28.368B | 18.53 |
| Terumo (TRUMY) | Japan | $19.441B | 21.97 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.819B | 11.11 |
| Insulet (PODD) | United States | $17.019B | 52.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.739B | 0.00 |
| Baxter (BAX) | United States | $11.170B | 9.02 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.133B | 29.24 |
| Demant (WILYY) | Denmark | $6.521B | 0.00 |
| Envista Holdings (NVST) | United States | $4.785B | 24.25 |
| Lantheus Holdings (LNTH) | United States | $4.303B | 13.11 |
| BillionToOne (BLLN) | United States | $4.147B | 0.00 |
| ICU Medical (ICUI) | United States | $3.806B | 24.16 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.189B | 14.81 |
| Haemonetics (HAE) | United States | $2.778B | 12.06 |
| Phibro Animal Health (PAHC) | United States | $2.151B | 18.95 |
| Perrigo (PRGO) | Ireland | $2.015B | 5.05 |
| LeMaitre Vascular (LMAT) | United States | $1.983B | 39.92 |
| QuidelOrtho (QDEL) | United States | $1.977B | 12.71 |
| AtriCure (ATRC) | United States | $1.845B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.622B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.486B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.475B | 64.64 |
| AdaptHealth (AHCO) | United States | $1.442B | 20.88 |
| Capricor Therapeutics (CAPR) | United States | $1.130B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.080B | 320.43 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.021B | 0.00 |
| InMode (INMD) | Israel | $0.953B | 10.77 |
| Tilray Brands (TLRY) | Canada | $0.883B | 0.00 |
| Valneva SE (VALN) | France | $0.817B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.803B | 0.00 |
| Omeros (OMER) | United States | $0.796B | 0.00 |
| CeriBell (CBLL) | United States | $0.747B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.587B | 15.91 |
| Verano Holdings (VRNO) | United States | $0.454B | 0.00 |
| Brainsway (BWAY) | Israel | $0.427B | 72.60 |
| Cerus (CERS) | United States | $0.423B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.405B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.377B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.328B | 26.18 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Evolus (EOLS) | United States | $0.292B | 0.00 |
| Quanterix (QTRX) | United States | $0.284B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.237B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.222B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.208B | 0.00 |
| Organigram Global (OGI) | Canada | $0.207B | 0.00 |
| High Tide (HITI) | Canada | $0.207B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.197B | 17.71 |
| Aurora Cannabis (ACB) | Canada | $0.197B | 58.00 |
| OraSure Technologies (OSUR) | United States | $0.194B | 0.00 |
| Accendra Health (ACH) | United States | $0.185B | 1.85 |
| Sanara MedTech (SMTI) | United States | $0.180B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.179B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.144B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.136B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.72 |
| MacroGenics (MGNX) | United States | $0.115B | 0.00 |
| Biote (BTMD) | United States | $0.102B | 4.46 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Exagen (XGN) | United States | $0.080B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 24.00 |
| Sharps Technology (STSS) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.042B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 29.77 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.033B | 16.63 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| ZeroStack (ZSTK) | United States | $0.010B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |